产品名称 |
产品编号 |
浓度/详细参数 |
CAS号 |
规格/计量单位 |
价格 |
货期 |
品牌 |
腺苷-5'-二磷酸单钾盐二水合物
|
A130017-1g
|
≥95% |
72696-48-1 |
1g
|
¥ 109.9
|
现货 |
阿拉丁 |
腺苷-5'-二磷酸单钾盐二水合物
|
A130017-100mg
|
≥95% |
72696-48-1 |
100mg
|
¥ 26.9
|
现货 |
阿拉丁 |
5-氨基-2,3-二氢苯并[b]呋喃
|
A130011-5g
|
≥97% |
42933-43-7 |
5g
|
¥ 229.9
|
期货,请咨询 |
阿拉丁 |
5-氨基-2,3-二氢苯并[b]呋喃
|
A130011-1g
|
≥97% |
42933-43-7 |
1g
|
¥ 71.9
|
期货,请咨询 |
阿拉丁 |
5-氨基-2,3-二氢苯并[b]呋喃
|
A130011-250mg
|
≥97% |
42933-43-7 |
250mg
|
¥ 38.9
|
期货,请咨询 |
阿拉丁 |
2-脒基吡啶盐酸盐
|
A130010-25g
|
≥97% |
51285-26-8 |
25g
|
¥ 112.9
|
现货 |
阿拉丁 |
2-脒基吡啶盐酸盐
|
A130010-5g
|
≥97% |
51285-26-8 |
5g
|
¥ 31.9
|
现货 |
阿拉丁 |
2-脒基吡啶盐酸盐
|
A130010-1g
|
≥97% |
51285-26-8 |
1g
|
¥ 29.9
|
现货 |
阿拉丁 |
阿西莫司
|
A129989-5g
|
Moligand™, ≥98% |
51037-30-0 |
5g
|
¥ 199.9
|
现货 |
阿拉丁 |
阿西莫司
|
A129989-1g
|
Moligand™, ≥98% |
51037-30-0 |
1g
|
¥ 84.9
|
现货 |
阿拉丁 |
5-氨基水杨酸
|
A129982-500g
|
Moligand™, ≥99% |
89-57-6 |
500g
|
¥ 399.9
|
期货,请咨询 |
阿拉丁 |
5-氨基水杨酸
|
A129982-100g
|
Moligand™, ≥99% |
89-57-6 |
100g
|
¥ 102.9
|
现货 |
阿拉丁 |
5-氨基水杨酸
|
A129982-25g
|
Moligand™, ≥99% |
89-57-6 |
25g
|
¥ 44.9
|
现货 |
阿拉丁 |
盐酸阿莫洛芬
|
A129973-1g
|
≥98%(HPLC) |
78613-38-4 |
1g
|
¥ 276.9
|
现货 |
阿拉丁 |
盐酸阿莫洛芬
|
A129973-250mg
|
≥98%(HPLC) |
78613-38-4 |
250mg
|
¥ 143.9
|
现货 |
阿拉丁 |
盐酸阿莫洛芬
|
A129973-50mg
|
≥98%(HPLC) |
78613-38-4 |
50mg
|
¥ 41.9
|
现货 |
阿拉丁 |
Aurora A Inhibitor I
|
A129933-50mg
|
Moligand™, ≥98%(HPLC) |
1158838-45-9 |
50mg
|
¥ 2594.9
|
现货 |
阿拉丁 |
Aurora A Inhibitor I
|
A129933-10mg
|
Moligand™, ≥98%(HPLC) |
1158838-45-9 |
10mg
|
¥ 833.9
|
现货 |
阿拉丁 |
Aurora A Inhibitor I
|
A129933-5mg
|
Moligand™, ≥98%(HPLC) |
1158838-45-9 |
5mg
|
¥ 589.9
|
现货 |
阿拉丁 |
(R)-(-)-醋酸棉酚
|
A129929-50mg
|
≥98% |
866541-93-7 |
50mg
|
¥ 3749.9
|
现货 |
阿拉丁 |
(R)-(-)-醋酸棉酚
|
A129929-10mg
|
≥98% |
866541-93-7 |
10mg
|
¥ 1051.9
|
现货 |
阿拉丁 |
AMG-900
|
A129924-50mg
|
Moligand™, ≥98% |
945595-80-2 |
50mg
|
¥ 959.9
|
现货 |
阿拉丁 |
AMG-900
|
A129924-10mg
|
Moligand™, ≥98% |
945595-80-2 |
10mg
|
¥ 575.9
|
现货 |
阿拉丁 |
AMG-900
|
A129924-5mg
|
Moligand™, ≥98% |
945595-80-2 |
5mg
|
¥ 444.9
|
现货 |
阿拉丁 |
-
联系客服
-
-
回到顶部